Neostem, Inc. (NASDAQ:NBS) Trend Analysis released that its initial positive data from its 161 patient Phase 2 PreSERVE AMI (or acute myocardial infarction) clinical examination. These data are based on all enroll patients being treated and having got six month follow-up for imaging and twelve month median length follow up for mortality, adverse events, serious adverse events (SAEs) and major adverse cardiac events (MACE). Neostem, Inc. (NASDAQ:NBS) stock price closed at $6.78 with the total traded volume of 1.97 Million shares. Its price to sales ratio ended at 14.51. Its market capitalization is 242.3 Million. The stock owned by the Financial Institutions was 19.60% while by insiders was 2.60%. Urban Outfitters Inc. (NASDAQ:URBN) Trend Analysis declared that its Q3 net income of $47.1M or $0.35 a share, as compared to $70.3M or $0.47 a share for the year-ago quarter. Net sales for the Q3 increased 5% to a record $814.47 million from $774.05 million in the same quarter last year.Urban Outfitters Inc. (NASDAQ:URBN) has the market capitalization of 4.142 Billion. Shares of firm plunged -0.06% to close at $30.83 with the total traded volume of 4.96 Million. The firm has current ratio of 2.20 for the most recent quarter.Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) Trend Analysis posted that FDA has permitted the trade name Auryxia (ferric citrate) for its FDA-approved ferric citrate. Auryxia, an iron-based phosphate binder, was permitted by the FDA to control serum phosphorus levels in patients with chronic kidney disease on dialysis in September 2014. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) begun last trade with a price of $15.51 and throughout the trading session climbed at a high of $15.6902. The day-trade ended with -0.20% to $15.18. The stock is going forward to its 52 week low with 31.66% and lagging behind from its 52 week high price with -17.86%. KERX last month stock price volatility remained 4.83%.
Most Volatile Stocks: Neostem, Inc. (NASDAQ:NBS), Urban Outfitters Inc. (NASDAQ:URBN), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX)







